Does anyone know approximately when FRX will receive or not receive approval for Celexa. If not a date, maybe within a month or two period. I understand the company may have received an approvable letter, but I don't believe the stock rallied the day the announcement came out, but I could be wrong. Does anyone have a feeling as to what the stock may do when the company gets a final approval or denial?
I believe the Celexa patent has already expired. If so, FDA will grant Forest 5 years of marketing exclusivity since citalopram is a new chemical entity (NCE). Generic companies will not be able to file applications for citalopram until the exclusivity expires, so the earliest generic approval date could be about 1 year after that - that's about how long a good ANDA takes to get approved nowadays.
But I do agree with lipolong, that Forest has the potential to be one fantastic investment. I certainly like that Roth Education IRA suggestion; I think I'll look into it myself.